ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,184, issued on Sept. 9, was assigned to Kura Oncology Inc. (San Diego).

"Crystalline forms of a menin inhibitor" was invented by Roger Paul Bakale (San Diego), Craig Michael Bowe (San Diego), Dipanjan Sengupta (San Diego), Patricia Andres (Bend, Ore.) and Xiaohu Deng (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are crystalline forms of (S)-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile or solvate thereof."

The patent was filed on Sept. 6, 2024, under Application No. 18/827,512.

*F...